| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_255741ec6a11404fcba9c1432ab7fbdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72ec5fdde21e1643a18752cd206e7dbb |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196 |
| filingDate |
2000-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84befe9ceee6c2787079e362d5bde430 |
| publicationDate |
2002-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2002128665-A |
| titleOfInvention |
Prostatic hyperplasia treatment |
| abstract |
(57) [Problem] To provide a remedy for prostatic hypertrophy which is more effective than a conventional remedy for prostatic hypertrophy. SOLUTION: The therapeutic agent for prostatic hypertrophy comprising a compound represented by the following structural formula as an active ingredient. |
| priorityDate |
2000-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |